12 - Biomolecular Engineering: General Concepts (cont.)
Listen now
Description
Professor Saltzman reviews the pharmacokinetic first-order rate equation that can be used to model changes in drug concentration in the blood, as well as its derivation from the law of conservation of mass. The importance of maintaining a drug concentration that is sufficient for therapeutic purpose, but below a toxic level, is emphasized. Since this is directly affected by drug administration method, ways to localize and sustain therapeutic concentrations of drug, such as incorporating in slow-releasing, biocompatible polymers are introduced. Professor Saltzman gave some examples of clinical applications of controlled release drug delivery system, such as anti-restenosis drug incorporated into stents, and chemotherapeutic drugs in brain implants and microspheres.
More Episodes
In this final lecture, Professor Saltzman talks about artificial organs, with a stress on synthetic biomaterials. First, the body's responses (immunological and scar healing responses) to foreign materials are introduced. This leads to discussion of different types of polymer/plastic materials...
Published 10/12/09
Professor Saltzman uses cancer diagnosis and treatment as an example to demonstrate the some applications of biomedical engineering technologies and methods. Some issues involved in cancer treatment, such as tumor angiogenesis, radiation sensitivity, drug localization, and cancer stem cells are...
Published 10/12/09
In this lecture, Professor Saltzman continues his discussion of tissue engineering, and its role in facilitating healing, tissue regeneration, organ replacement, drug delivery and as model for studying human physiology. Specific examples from current research by scientists at Yale are used to...
Published 10/12/09